Table1_Longitudinal Trend of Plasma Concentrations of Extracellular Vesicles in Patients Hospitalized for COVID-19.DOCX
Plasma concentrations of extracellular vesicles (EVs) originating from cells involved in COVID-19-associated coagulopathy (CAC), their longitudinal trend and association with clinical outcomes were evaluated. Blood samples of consecutive COVID-19 patients admitted to a medical Unit were longitudinally collected within 48 h of admission, at discharge and 30 days post-discharge. EVs were analyzed using high sensitivity flow cytometry and phospholipid-dependent clotting time (PPL). The following EVs were measured: endothelium-, platelet-, leukocyte-derived, bearing tissue factor (TF)+, angiotensin-converting enzyme (ACE2)+, platelet-derived growth factor receptor-β (PDGF-β)+ and SARS-CoV-2-nucleoprotein (NP)+. 91 patients were recruited for baseline EV analysis (mean age 67 ± 14 years, 50.5% male) and 48 underwent the longitudinal evaluation. From baseline to 30-days post-discharge, we observed significantly decreased plasma concentrations of endothelium-derived EVs (E-Selectin+), endothelium-derived bearing TF (E-Selectin+ TF+), endothelium-derived bearing ACE2 (E-Selectin+ACE2+) and leukocyte-EVs bearing TF (CD45+TF+), p < 0.001, p = 0.03, p = 0.001, p = 0.001, respectively. Conversely, platelet-derived (P-Selectin+) and leukocyte-derived EVs (CD45+) increased from baseline to 30-days post-discharge (p = 0.038 and 0.032, respectively). EVs TF+, ACE2+, PDGF-β+, and SARS-CoV-2-NP+ did not significantly change during the monitoring. PPL increased from baseline to 30-days post-discharge (+ 6.3 s, p = 0.006). P-Selectin + EVs >1,054/µL were associated with thrombosis (p = 0.024), E-Selectin + EVs ≤531/µL with worsening/death (p 0.026) and 30-days P-Selectin+ and CD45 + EVs with persistent symptoms (p < 0.0001). We confirmed increased EVs originating from cells involved in CAC at admission and discharge. EVs derived from activated pericytes and expressing SARS-CoV-2-NP were also detected. 30-days post-discharge, endothelium-EVs decreased, while platelet- and leukocyte-EVs further increased, indicating that cellular activation persists long after the acute phase.
History
References
- https://doi.org//10.1038/s41418-021-00805-z
- https://doi.org//10.1161/01.RES.0000182903.16652.d7
- https://doi.org//10.1111/cts.12907
- https://doi.org//10.1016/j.ebiom.2021.103369
- https://doi.org//10.1093/infdis/jiaa273
- https://doi.org//10.1515/cclm-2021-0108
- https://doi.org//10.1002/cyto.b.21507
- https://doi.org//10.1160/th12-05-0280
- https://doi.org//10.1097/mbc.0000000000000068
- https://doi.org//10.2217/bmm-2015-0063
- https://doi.org//10.1007/s11739-016-1397-7
- https://doi.org//10.1016/j.dld.2020.12.118
- https://doi.org//10.1016/j.jacbts.2020.12.009
- https://doi.org//10.3390/cells10010085
- https://doi.org//10.1097/mbc.0b013e32832ee915
- https://doi.org//10.1182/blood.2020006000
- https://doi.org//10.1016/j.jviromet.2006.06.029
- https://doi.org//10.1371/journal.pone.0245835
- https://doi.org//10.1016/j.ahjo.2021.100025
- https://doi.org//10.1161/atvbaha.120.315595
- https://doi.org//10.1213/ane.0000000000005147
- https://doi.org//10.1161/atvbaha.114.304114
- https://doi.org//10.1161/atvbaha.117.309846
- https://doi.org//10.1182/bloodadvances.2020003308
- https://doi.org//10.1002/path.1570
- https://doi.org//10.1101/2020.05.11.088500
- https://doi.org//10.1182/blood.2020007252
- https://doi.org//10.1186/s13054-020-03077-0
- https://doi.org//10.1111/jth.14975
- https://doi.org//10.3390/v13050767
- https://doi.org//10.1111/jth.12207
- https://doi.org//10.1016/j.mayocp.2020.10.031
- https://doi.org//10.1161/ATVBAHA.121.316203
- https://doi.org//10.1182/blood.2020007214
- https://doi.org//10.3390/v6082991
- https://doi.org//10.1002/cyto.a.22647
- https://doi.org//10.1111/jth.14481
- https://doi.org//10.1002/rth2.12439
- https://doi.org//10.1161/circresaha.110.233056
- https://doi.org//10.1161/atvbaha.120.315547
- https://doi.org//10.1152/ajpheart.00925.2020
- https://doi.org//10.1055/s-0040-1710018
- https://doi.org//10.1055/a-1522-4131
- https://doi.org//10.1111/jth.13190
- https://doi.org//10.1016/s0140-6736(20)30937-5
- https://doi.org//10.1186/1750-1326-5-32
- https://doi.org//10.1002/cyto.a.22892
- https://doi.org//10.1161/circresaha.120.317703
- https://doi.org//10.1186/s13045-020-00954-7
CC BY 4.0